Bilateral Vestibular Hypofunction: Insights in Etiologies, Clinical Subtypes, and Diagnostics.
F Lucieer, P Vonk, N Guinand...
https://pubmed.ncbi.nlm.nih.gov/26973594/Actively Recruiting
Led by Johns Hopkins University · Updated on 2026-03-27
90
Participants Needed
2
Research Sites
N/A
Total Duration
Researchers are studying the effect of a vibrotactile feedback belt, called the BalanceBelt, on improving walking ability in people with gait and balance disorders such as vestibular hypofunction and ataxia. The study compares individuals with balance disorders to healthy participants without such disorders to understand how the device may support better balance and mobility. Participants with balance challenges will wear the BalanceBelt, a lightweight device worn around the waist that provides real-time vibration signals to help improve posture and stability during daily activities. The control group consists of healthy adults matched by age and gender who will not use the device but undergo the same assessments. The study uses various tests including the video head impulse test, dynamic visual acuity test, and wearable sensors to analyze gait and balance. During the study, participants will complete repeated evaluations over several months, including questionnaires measuring dizziness impact, balance confidence, and vestibular symptoms, along with physical tests assessing gait and posture. Measurements occur at baseline, 3 weeks, and multiple follow-up points up to 35 months. Researchers will monitor safety and changes in functional ability to better understand how vibrotactile feedback may aid those with balance impairments.
CONDITIONS
Vibrotactile Balance Belt Effect on Improving Gait
M
Michael Craig Schubert, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Johns Hopkins University
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | BalanceBelt Device Group | Healthy Control Group |
|---|---|---|
| What it is | A group of adults with balance disorders using the BalanceBelt, a wearable device that provides real-time vibrotactile feedback to help maintain stability during movement. | A group of healthy adults without balance disorders who do not receive any device or intervention, serving as a reference group for assessing normal balance and gait. |
| Role in the trial | Evaluated for improvement in stability, gait, and balance function after using the BalanceBelt device. | Provide normal reference values and comparison data for gait and balance, without receiving intervention. |
| Primary use | Provides sensory feedback via vibration to assist adults with balance impairment in daily movement, aiming to improve safety, confidence, and independence. | No intervention provided; this group represents expected balance ability in adults without vestibular or gait issues. |
| How it is given or performed | Participants wear the BalanceBelt around the waist during everyday activities, receiving real-time vibration feedback corresponding to trunk tilt and movement. | Participants in this group do not use any device or receive intervention. |
| Evidence status | Prior studies of vibrotactile feedback devices, including the BalanceBelt, have shown improved balance and mobility in people with bilateral vestibular loss or similar disorders, with effects sustained during device use. | Healthy individuals generally demonstrate stable gait and balance without assistive devices. Study outcomes in this group provide expected normative performance for adults without vestibular or gait impairment. |
| Important limitations | Benefits of the BalanceBelt may depend on continued device use; evidence is largely from short-term or single-center trials. Long-term safety and effectiveness outside of specialized centers are not fully established. | This group does not have balance disorder, so findings do not reflect effects of intervention or disease. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 3 weeks
Participants with balance disorders will wear a vibrotactile stimulation device called the BalanceBelt to assist with balance during daily activities. The device provides real-time feedback around the waist to improve stability and mobility. Healthy control participants will not receive any intervention.
Baseline visit and follow-up visits at 3 weeks and monthly up to 4 months
Duration - Up to 35 months
Participants are monitored over an extended period to assess balance, gait, and quality of life outcomes using various tests and questionnaires.
Follow-up visits occurring at 5, 11, 23, and 35 months
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
F Lucieer, P Vonk, N Guinand...
https://pubmed.ncbi.nlm.nih.gov/26973594/J Hegeman, F Honegger, M Kupper...
https://pubmed.ncbi.nlm.nih.gov/15951624/Lisa van Stiphout, David J Szmulewicz, Nils Guinand...
https://pubmed.ncbi.nlm.nih.gov/38178884/Marco Dozza, Lorenzo Chiari, Fay B Horak
https://pubmed.ncbi.nlm.nih.gov/16003671/Jean-Philippe Guyot, A Perez Fornos, N Guinand...
https://pubmed.ncbi.nlm.nih.gov/27083882/Herman Kingma, Lilian Felipe, Marie-Cecile Gerards...
https://pubmed.ncbi.nlm.nih.gov/30519776/Dmitrii Starkov, Michael Strupp, Maksim Pleshkov...
https://pubmed.ncbi.nlm.nih.gov/32767115/Herman Kingma, Dan Dupont Hougaard, Raymond van de Berg
https://pubmed.ncbi.nlm.nih.gov/39440249/Lorenzo Chiari, Marco Dozza, Angelo Cappello...
https://pubmed.ncbi.nlm.nih.gov/16366234/Sinem Balta Beylergil, Faisal Karmali, Wei Wang...
https://pubmed.ncbi.nlm.nih.gov/31239136/Johns Hopkins University
Lead Sponsor